GleamWall
中文EN

VJET Flyte Aviation, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1716621 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY599.8%
TTM net income YoY-51.9%
TTM EPS YoY89.8%
Revenue 3-yr CAGR124.0%
Net income 3-yr CAGR—

Margins

Gross margin29.2%
Operating margin-527.1%
Net margin-733.4%
FCF margin-331.6%
EBITDA margin-499.9%

Returns

ROE-273.6%
ROA-104.1%
ROIC (approx.)-173.4%
Asset turnover0.14x

Leverage & solvency

Liabilities / assets51.7%
Debt / equity0.00x
Current ratio0.54x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.45x
Accruals ratio-57.1%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$819,000$420,000
Cost of revenue$63,000$42,000
Gross profit$756,000$378,000
R&D expense$862,000$272,000
SG&A expense$12.07M$11.35M
Operating income-$21.14M-$11.24M
Pretax income-$19.50M-$13.50M
Income tax-$1.81M$3.14M
Net income-$17.18M-$16.64M
EBITDA-$19.03M-$9.13M
EPS (basic)-15.90-126.91
EPS (diluted)——
Balance sheet
Cash & equivalents$88,000$2.87M
Short-term investments$0—
Receivables$155,000$70,000
Inventory$86,000$33,000
Current assets$390,000$3.29M
PP&E, net$0$91,000
Goodwill$0—
Intangibles$0$24.27M
Total assets$15.86M$27.77M
Current liabilities$3.91M$2.23M
Short-term debt$0—
Long-term debt$3.08M—
Total debt$3.08M—
Total liabilities$9.21M$16.01M
Shareholders' equity$7.05M$11.76M
Net debt$2.99M—
Shares outstanding173,896421,296
Cash flow statement
Operating cash flow-$8.30M-$9.27M
Capital expenditure$17,000$67,000
Free cash flow-$8.31M-$9.34M
Investing cash flow$167,000-$67,000
Financing cash flow$5.34M$8.65M
Depreciation & amortization$2.12M$2.11M
Stock-based compensation$338,000$54,000

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.